Page last updated: 2024-08-21

dihydroergotamine and butorphanol

dihydroergotamine has been researched along with butorphanol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Belgrade, MJ; Ettinger, MG; Ling, LJ; Ruiz, E; Schleevogt, MB1
Kumar, KL1

Reviews

2 review(s) available for dihydroergotamine and butorphanol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Recent advances in the acute management of migraine and cluster headaches.
    Journal of general internal medicine, 1994, Volume: 9, Issue:6

    Topics: Analgesics; Butorphanol; Capsaicin; Cluster Headache; Dihydroergotamine; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Sumatriptan; Tolmetin

1994

Trials

1 trial(s) available for dihydroergotamine and butorphanol

ArticleYear
Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache.
    Neurology, 1989, Volume: 39, Issue:4

    Topics: Adult; Butorphanol; Clinical Trials as Topic; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Hydroxyzine; Male; Meperidine; Metoclopramide; Morphinans; Vascular Headaches

1989

Other Studies

1 other study(ies) available for dihydroergotamine and butorphanol

ArticleYear
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010